All Phenotypes Igf1<tm1Dlr> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Igf1^tm1Dlr/Igf1^tm1Dlr Igfals^tm1Yrb/Igfals^tm1Yrb Tg(Alb1-cre)1Dlr/?	involves: 129S4/SvJae * BALB/c * C57BL/6 * FVB/N	MGI:3603650
cn2	Igf1^tm1Dlr/Igf1^tm1Dlr Tg(Mx1-cre)1Cgn/0	involves: 129/Sv * C57BL/6 * CBA	MGI:2176943
cn3	Igf1^tm1Dlr/Igf1^tm1Dlr Tg(EIIa-cre)C5379Lmgd/0	involves: 129/Sv * C57BL/6 * FVB/N	MGI:2176942
cn4	Igf1^tm1Dlr/Igf1^tm1Dlr Tg(Alb1-cre)1Dlr/0	involves: 129/Sv * C57BL/6 * FVB/N	MGI:2176949
cn5	Igf1^tm1Dlr/Igf1^tm1Dlr Tg(Alb1-cre)1Dlr/0	involves: 129/Sv * C57BL/6J * FVB/N	MGI:4430376
cn6	Igf1^tm1Dlr/Igf1^tm1Dlr Tg(Serpina1e-cre/ERT)1Sykr/0	involves: 129/Sv * C57BL/6J * FVB/N	MGI:4430378

Allelic Composition	Igf1^tm1Dlr/Igf1^tm1Dlr Igfals^tm1Yrb/Igfals^tm1Yrb Tg(Alb1-cre)1Dlr/?
Genetic Background	involves: 129S4/SvJae * BALB/c * C57BL/6 * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Igf1^tm1Dlr mutation (2 available); any Igf1 mutation (29 available)
Igfals^tm1Yrb mutation (1 available); any Igfals mutation (33 available)
Tg(Alb1-cre)1Dlr mutation (3 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

Igf1^tm1Dlr/Igf1^tm1Dlr Igfals^tm1Yrb/Igfals^tm1Yrb Tg(Alb1-cre)1Dlr/? mice exhibit reduced growth plate height

growth/size/body

decreased body length ( J:79109 )

• 30% reduction in total length by 2-3 weeks of age

skeleton

abnormal limb bone morphology ( J:79109 )

abnormal femur morphology ( J:79109 )

• reduced cortical bone thickness

• reduced trabecular bone volume and trabecular bone density

decreased diameter of femur ( J:79109 )

short femur ( J:79109 )

• 20% shorter at 21 days of age and 12% shorter at 6 weeks of age

abnormal long bone epiphyseal plate proliferative zone ( J:79109 )

• reduced 15 %

decreased width of hypertrophic chondrocyte zone ( J:79109 )

• reduced 26%

decreased long bone epiphyseal plate size ( J:79109 )

• tibial growth plate height reduced by 20%

• germinal zone height increased in the tibia

limbs/digits/tail

abnormal limb bone morphology ( J:79109 )

abnormal femur morphology ( J:79109 )

• reduced cortical bone thickness

• reduced trabecular bone volume and trabecular bone density

decreased diameter of femur ( J:79109 )

short femur ( J:79109 )

• 20% shorter at 21 days of age and 12% shorter at 6 weeks of age

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

homeostasis/metabolism

homeostasis/metabolism phenotype ( J:121798 )

N	• after induction with PiPc, 6-mo-old mice exhibit no significant differences in serum and urine creatinine levels relative to control mice

decreased circulating insulin-like growth factor I level ( J:55718 , J:121798 )

• after induction with IFN at 24-28 days of age, mice exhibit a 75% reduction in serum IGF-I levels relative to control mice, still evident at 53 days of age (J:55718)

• after induction with PiPc at 4 weeks of age, mice exhibit a 80-85% reduction in serum IGF-I levels relative to control mice, still evident at 24 months of age (J:121798)

• renal IGF-II mRNA levels are reduced by 79%, suggesting that the effects of circulating IGF-I on kidney size may be mediated by renal IGF-II; however, no differences in serum IGF-II levels are observed at 9 months (J:121798)

increased circulating growth hormone level ( J:121798 )

• after induction with PiPc, mice exhibit compensatory increased circulating GH levels relative to control mice

increased urine potassium level ( J:121798 )

• after induction with PiPc, 6-mo-old mice exhibit increased 24-hr potassium excretion relative to control mice

increased urine sodium level ( J:121798 )

• after induction with PiPc, 6-mo-old mice exhibit increased 24-hr sodium excretion relative to control mice

growth/size/body

growth/size/body region phenotype ( J:55718 , J:121798 )

• after induction with IFN at 24-28 days of age, mice exhibit normal postnatal body growth up to 53 days of age relative to control mice (J:55718)

• after induction with PiPc at 4 weeks of age, mice exhibit no significant differences in body weight relative to control mice, as shown at 7 and 24 months of age (J:121798)

renal/urinary system

renal/urinary system phenotype ( J:121798 )

• after induction with PiPc, 6-mo-old mice exhibit no significant differences in serum and urine creatinine levels, GFR, creatinine clearance, or 24-hr urine volume relative to control mice

• no glomerulosclerosis, vascular defects, mesangial sclerosis, or cortical fibrosis is observed at 24 months of age

increased urine potassium level ( J:121798 )

• after induction with PiPc, 6-mo-old mice exhibit increased 24-hr potassium excretion relative to control mice

increased urine sodium level ( J:121798 )

• after induction with PiPc, 6-mo-old mice exhibit increased 24-hr sodium excretion relative to control mice

decreased kidney weight ( J:121798 )

• after induction with PiPc, absolute and relative kidney weight is reduced in 7- and 24-month-old mice relative to control mice

cardiovascular system

increased systemic arterial systolic blood pressure ( J:121798 )

• after induction with PiPc, 7-mo-old mice exhibit increased systolic blood pressure relative to control mice

Allelic Composition	Igf1^tm1Dlr/Igf1^tm1Dlr Tg(EIIa-cre)C5379Lmgd/0
Genetic Background	involves: 129/Sv * C57BL/6 * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Igf1^tm1Dlr mutation (2 available); any Igf1 mutation (29 available)
Tg(EIIa-cre)C5379Lmgd mutation (4 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

perinatal lethality, incomplete penetrance ( J:49468 )

• some perinatal mortality but many survive

growth/size/body

slow postnatal weight gain ( J:49468 )

• 72% of control weight at 3 weeks of age, 68% at 6 weeks

fetal growth retardation ( J:49468 )

• fetus at E19 or E20 weighs only 69% as much as comparable controls

Allelic Composition	Igf1^tm1Dlr/Igf1^tm1Dlr Tg(Alb1-cre)1Dlr/0
Genetic Background	involves: 129/Sv * C57BL/6 * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Igf1^tm1Dlr mutation (2 available); any Igf1 mutation (29 available)
Tg(Alb1-cre)1Dlr mutation (3 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

normal phenotype

no abnormal phenotype detected ( J:69517 )

Allelic Composition	Igf1^tm1Dlr/Igf1^tm1Dlr Tg(Alb1-cre)1Dlr/0
Genetic Background	involves: 129/Sv * C57BL/6J * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Igf1^tm1Dlr mutation (2 available); any Igf1 mutation (29 available)
Tg(Alb1-cre)1Dlr mutation (3 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

homeostasis/metabolism

decreased circulating insulin-like growth factor I level ( J:155733 )

• male mutant LID (LID, chronic liver-specific IGF-1 deficiency) mice fed a high calorie or regular diet for 8 to 10 weeks exhibit decreased serum IGF-1 levels relative to controls

increased circulating leptin level ( J:155733 )

• LID mice fed a high calorie for 8 to 10 weeks exhibit increased serum leptin levels compared to lean LID mice (fed a regular diet)

neoplasm

decreased tumor growth/size ( J:155733 )

• male double mutant (LID, chronic liver-specific IGF-1 deficiency) mice on a high calorie diet for 10-14 weeks and injected with subcutaneous MC-39 murine colorectal carcinoma cell do not show the obesity-associated increase in local tumor growth compared to lean controls

Allelic Composition	Igf1^tm1Dlr/Igf1^tm1Dlr Tg(Serpina1e-cre/ERT)1Sykr/0
Genetic Background	involves: 129/Sv * C57BL/6J * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Igf1^tm1Dlr mutation (2 available); any Igf1 mutation (29 available)
Tg(Serpina1e-cre/ERT)1Sykr mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

homeostasis/metabolism

homeostasis/metabolism phenotype ( J:155733 )

N	• serum adiponectin and glucose levels in obese iLID mice are comparable to lean iLID mice (iLID, inducible liver-specific IGF-1 deficiency)

increased circulating insulin level ( J:155733 )

• iLID mice fed a high calorie for 8 to 10 weeks and then injected with tamoxifen exhibit increased serum insulin levels compared to tamoxifen-treated lean mice (fed a regular diet)

decreased circulating insulin-like growth factor I level ( J:155733 )

• mutant mice (iLID, inducible liver-specific IGF-1 deficiency) fed a high calorie or regular diet for 8 to 10 weeks and then injected with tamoxifen exhibit decreased serum IGF-1 levels relative to tamoxifen-treated controls

increased circulating leptin level ( J:155733 )

• iLID mice fed a high calorie for 8 to 10 weeks and then injected with tamoxifen exhibit increased serum leptin levels compared to tamoxifen-treated lean mice (fed a regular diet)

neoplasm

neoplasm ( J:155733 )

N	• tamoxifen treatment of lean or obese mice before or after injection of MC-38 colon carcinoma cells does not alter the obesity-associated increase in tumor growth in contrast to what is observed in LID (chronic liver-specific IGF-1 deficiency) mice

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 12/17/2024 MGI 6.24